Literature DB >> 9279242

Tuberculosis prevention among foreign-born persons in Seattle--King County, Washington.

C D Wells1, P L Zuber, C M Nolan, N J Binkin, S V Goldberg.   

Abstract

The purpose of this study was to evaluate the outcomes of classified immigrant and refugee (I&R) screening and of contact investigation (CI) of foreign-born TB cases in Seattle--King County (SKC), Washington. We reviewed I&R evaluations from the SKC TB clinic for 1992-1994 and contact evaluation records for 54 randomly selected U.S.-born and foreign-born pulmonary TB patients from 1993. Among 942 I&R evaluated, 693 (74%) had positive tuberculin skin tests (TST). Preventive therapy (PT) was prescribed for 324 (34%) and treatment for 49 (5%). The remaining 377 were dismissed, of whom 96% did not meet American Thoracic Society PT criteria. Contacts of foreign-born cases were more numerous (6.0 versus 3.4 per case, p = 0.04), and significantly more likely to be TST-positive (50% versus 18%) and to be started on PT (40% versus 23%). The large number of I&R eligible for treatment or PT emphasizes the benefit of prompt evaluation of new arrivals. CI provides an excellent opportunity to screen foreign-born persons at high risk for active TB.

Entities:  

Mesh:

Year:  1997        PMID: 9279242     DOI: 10.1164/ajrccm.156.2.9611101

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  9 in total

1.  The journey to wellness: stages of refugee health promotion and disease prevention.

Authors:  Lawrence A Palinkas; Sheila M Pickwell; Kendra Brandstein; Terry J Clark; Linda L Hill; Robert J Moser; Abdikadir Osman
Journal:  J Immigr Health       Date:  2003-01

2.  Tuberculosis control: challenges of an ancient and ongoing epidemic.

Authors:  Kristin J Cummings
Journal:  Public Health Rep       Date:  2007 Sep-Oct       Impact factor: 2.792

3.  Impact of port of entry referrals on initiation of follow-up evaluations for immigrants with suspected tuberculosis: Illinois.

Authors:  Teal R Bell; NoelleAngelique M Molinari; Sena Blumensaadt; Monica U Selent; Michael Arbisi; Neha Shah; Demian Christiansen; Rossanne Philen; Benjamin Puesta; Joshua Jones; Deborah Lee; Arnold Vang; Nicole J Cohen
Journal:  J Immigr Minor Health       Date:  2013-08

4.  Tuberculosis screening among foreign-born persons applying for permanent US residence.

Authors:  Mona Saraiya; Susan T Cookson; Paul Tribble; Benjamin Silk; Robert Cass; Shameer Poonja; Marva Walting; Noelle Howland; Edwin A Paz; Jennifer Cochran; Kathleen S Moser; Margaret J Oxtoby; Nancy J Binkin
Journal:  Am J Public Health       Date:  2002-05       Impact factor: 9.308

Review 5.  Tuberculosis: evidence review for newly arriving immigrants and refugees.

Authors:  Christina Greenaway; Amelia Sandoe; Bilkis Vissandjee; Ian Kitai; Doug Gruner; Wendy Wobeser; Kevin Pottie; Erin Ueffing; Dick Menzies; Kevin Schwartzman
Journal:  CMAJ       Date:  2010-07-15       Impact factor: 8.262

6.  Tuberculosis among foreign-born children in the state of Florida, 1993-1999: a re-emergence phase after a sustained decline?

Authors:  Hamisu M Salihu; Robyn Spittle
Journal:  Wien Klin Wochenschr       Date:  2003-09-30       Impact factor: 1.704

7.  Community-based evaluation of immigrant tuberculosis screening using interferon γ release assays and tuberculin skin testing: observational study and economic analysis.

Authors:  Manish Pareek; Marion Bond; Jennifer Shorey; Suranjith Seneviratne; Margaret Guy; Peter White; Ajit Lalvani; Onn Min Kon
Journal:  Thorax       Date:  2012-06-12       Impact factor: 9.139

Review 8.  Contact investigation for tuberculosis: a systematic review and meta-analysis.

Authors:  Gregory J Fox; Simone E Barry; Warwick J Britton; Guy B Marks
Journal:  Eur Respir J       Date:  2012-08-30       Impact factor: 16.671

Review 9.  The impact of migration on tuberculosis epidemiology and control in high-income countries: a review.

Authors:  Manish Pareek; Christina Greenaway; Teymur Noori; Jose Munoz; Dominik Zenner
Journal:  BMC Med       Date:  2016-03-23       Impact factor: 8.775

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.